Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: USA Bonds: Other Debt, Reduced, 2017 Q2

CITADEL ADVISORS LLC historic quarter change: USA Bonds: Other Debt, Reduced

In other debt filed by principal amount (debentures, bonds) (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 884 positions, added to 1,270, reduced 1,104 and sold out of 996.

  • Q2 2017: Stock CEMEX SAB DE CV; Country of operation —; Class Bond; Principal before $50,300,000.
  • Q2 2017: Stock NOVELLUS SYS INC; Country of operation —; Class Bond; Principal before $114,034,000.
  • Q2 2017: Stock VERISIGN INC; Country of operation —; Class Bond; Principal before $198,227,000.
  • Q2 2017: Stock PANDORA MEDIA INC; Country of operation —; Class Bond; Principal before $52,000,000.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassPrincipal beforePrincipal afterShare changeValue beforeValue afterValue changeFiled
Q2 2017CEMEX SAB DE CV
CUSIP 151290BC6
—Bond$50,300,000$35,300,000-15,000,000$58,768$5,327-$53,4412017-08-11
Q2 2017NOVELLUS SYS INC
CUSIP 670008AD3
—Bond$114,034,000$112,034,000-2,000,000$432,651$469,668+$37,0172017-08-11
Q2 2017VERISIGN INC
CUSIP 92343EAD4
—Bond$198,227,000$175,627,000-22,600,000$506,278$478,587-$27,6912017-08-11
Q2 2017PANDORA MEDIA INC
CUSIP 698354AB3
—Bond$52,000,000$27,500,000-24,500,000$52,036$26,147-$25,8892017-08-11
Q2 2017INTEL CORP
CUSIP 458140AF7
—Bond$18,000,000$8,000,000-10,000,000$31,458$13,218-$18,2402017-08-11
Q2 2017MEDICINES CO
CUSIP 584688AE5
—Bond$19,000,000$10,000,000-9,000,000$30,006$13,016-$16,9902017-08-11
Q2 2017TAL ED GROUP
CUSIP 874080AB0
—Bond$32,000,000$31,425,000-575,000$129,785$146,652+$16,8672017-08-11
Q2 2017SEACOR HOLDINGS INC
CUSIP 81170YAB5
—Bond$50,343,000$34,093,000-16,250,000$45,012$28,935-$16,0772017-08-11
Q2 2017CONVERGYS CORP
CUSIP 212485AE6
—Bond$27,549,000$17,549,000-10,000,000$54,577$38,820-$15,7572017-08-11
Q2 2017CARDTRONICS INC
CUSIP 14161HAG3
—Bond$18,931,000$11,431,000-7,500,000$20,560$10,920-$9,6402017-08-11
Q2 2017AMTRUST FINL SVCS INC
CUSIP 032359AG6
—Bond$27,650,000$16,650,000-11,000,000$20,500$12,489-$8,0112017-08-11
Q2 2017ECHO GLOBAL LOGISTICS INC
CUSIP 27875TAA9
—Bond$13,000,000$5,750,000-7,250,000$12,352$5,485-$6,8672017-08-11
Q2 2017VECTOR GROUP LTD
CUSIP 92240MBC1
—Bond$33,845,000$27,845,000-6,000,000$38,424$32,018-$6,4062017-08-11
Q2 2017VITAMIN SHOPPE INC
CUSIP 92849EAB7
—Bond$34,500,000$29,500,000-5,000,000$29,444$23,304-$6,1402017-08-11
Q2 2017ALLSCRIPTS HEALTHCARE SOLUTN
CUSIP 01988PAD0
—Bond$12,500,000$7,500,000-5,000,000$12,585$7,617-$4,9682017-08-11
Q2 2017CSG SYS INTL INC
CUSIP 126349AF6
—Bond$21,892,000$16,500,000-5,392,000$22,691$17,874-$4,8172017-08-11
Q2 2017SPECTRANETICS CORP
CUSIP 84760CAA5
—Bond$33,150,000$31,650,000-1,500,000$38,092$42,855+$4,7632017-08-11
Q2 2017IMMUNOMEDICS INC
CUSIP 452907AK4
—Bond$13,990,000$12,990,000-1,000,000$19,718$23,907+$4,1892017-08-11
Q2 2017INVACARE CORP
CUSIP 461203AF8
—Bond$37,500,000$31,500,000-6,000,000$37,964$33,929-$4,0352017-08-11
Q2 2017BROADSOFT INC
CUSIP 11133BAB8
—Bond$23,636,000$19,636,000-4,000,000$26,627$22,680-$3,9472017-08-11
Q2 2017AK STL CORP
CUSIP 001546AP5
—Bond$9,045,000$7,045,000-2,000,000$14,339$10,437-$3,9022017-08-11
Q2 2017SOLARCITY CORP
CUSIP 83416TAA8
—Bond$6,000,000$2,000,000-4,000,000$5,818$1,998-$3,8202017-08-11
Q2 2017GLOBAL EAGLE ENTMT INC
CUSIP 37951DAB8
—Bond$46,420,000$44,420,000-2,000,000$25,528$29,151+$3,6232017-08-11
Q2 2017HERBALIFE LTD
CUSIP 42703MAB9
—Bond$80,500,000$77,500,000-3,000,000$77,158$80,761+$3,6032017-08-11
Q2 2017NATIONAL HEALTH INVS INC
CUSIP 63633DAE4
—Bond$43,274,000$38,349,000-4,925,000$48,241$44,779-$3,4622017-08-11
Q2 2017RTI INTL METALS INC
CUSIP 74973WAB3
—Bond$7,539,000$5,000,000-2,539,000$8,792$5,341-$3,4512017-08-11
Q2 2017COBALT INTL ENERGY INC
CUSIP 19075FAA4
—Bond$18,000,000$11,000,000-7,000,000$5,927$2,702-$3,2252017-08-11
Q2 2017VERINT SYS INC
CUSIP 92343XAA8
—Bond$11,500,000$9,000,000-2,500,000$11,345$8,831-$2,5142017-08-11
Q2 2017BROOKDALE SR LIVING INC
CUSIP 112463AA2
—Bond$7,000,000$4,500,000-2,500,000$6,894$4,470-$2,4242017-08-11
Q2 2017COMCAST HOLDINGS CORP
CUSIP 200300507
—Bond$78,835,209$78,120,009-715,200$56,492$58,847+$2,3552017-08-11
Q2 2017KEYW HLDG CORP
CUSIP 493723AA8
—Bond$35,855,000$33,855,000-2,000,000$34,774$32,738-$2,0362017-08-11
Q2 2017MEDIDATA SOLUTIONS INC
CUSIP 58471AAB1
—Bond$9,000,000$6,000,000-3,000,000$10,270$8,381-$1,8892017-08-11
Q2 2017REPLIGEN CORP
CUSIP 759916AA7
—Bond$15,103,000$12,103,000-3,000,000$19,172$17,388-$1,7842017-08-11
Q2 2017PORTFOLIO RECOVERY ASSOCS IN
CUSIP 73640QAB1
—Bond$7,316,000$5,316,000-2,000,000$6,592$5,076-$1,5162017-08-11
Q2 2017INOTEK PHARMACEUTICALS CORP
CUSIP 45780VAB8
—Bond$10,500,000$8,500,000-2,000,000$6,476$5,143-$1,3332017-08-11
Q2 2017COWEN INC
CUSIP 223622AB7
—Bond$25,500,000$24,000,000-1,500,000$25,867$24,709-$1,1582017-08-11
Q2 2017GOGO INC
CUSIP 38046CAB5
—Bond$37,535,000$35,260,000-2,275,000$31,064$32,100+$1,0362017-08-11
Q2 2017TERRAVIA HLDGS INC
CUSIP 83415TAC5
—Bond$18,500,000$18,000,000-500,000$7,717$6,755-$9622017-08-11
Q2 2017ENDOLOGIX INC
CUSIP 29266SAA4
—Bond$2,020,000$1,250,000-770,000$1,950$1,190-$7602017-08-11
Q2 2017OREXIGEN THERAPEUTICS INC
CUSIP 686164AC8
—Bond$3,000,000$2,000,000-1,000,000$1,463$1,000-$4632017-08-11
Q2 2017AMYRIS INC
CUSIP 03236MAF8
—Bond$6,000,000$5,000,000-1,000,000$3,150$3,537+$3872017-08-11
Q2 2017PTC THERAPEUTICS INC
CUSIP 69366JAB7
—Bond$21,100,000$17,350,000-3,750,000$13,619$13,603-$162017-08-11